Prous Science

Last updated
Prous Science
IndustryHealth Science Publishing
FateAcquired by Thomson Reuters
Founded1965;55 years ago (1965)
Defunct2007 (2007)
Headquarters,
Subsidiaries Prous Institute for Biomedical Research

Prous Science was an international health science publishing company, established in 1965 and headquartered in Barcelona, Catalonia, Spain. The company was acquired by Thomson Reuters in 2007.

Contents

The Prous Institute for Biomedical Research was founded in 2000 by Dr Josep Prous Jr as a spinoff biotech company of Prous Science. [1] Dr. J.R. Prous was the CEO and president of Prous Science.Its head offices are located in Barcelona and it has subsidiaries in Philadelphia (United States), Buenos Aires (Argentina) and Tokyo (Japan). Its research is based on the use of datamining, statistical analysis and chemoinformatic techniques, a recent and innovative international concept registered under the name "druginformatics". These techniques are complemented by laboratory methods from combinatorial chemistry, molecular biology and functional genomics.

Science

The 'Prous Scientific Integrity' data portal was launched in 2001. [2] In 2008, Prous pharmacology and drug discovery content was made available through Thomson Reuters services. [3] [4]

See also

Related Research Articles

Pharmacology Branch of biology concerning drugs

Pharmacology is a branch of medicine and pharmaceutical sciences which is concerned with the study of drug or medication action, where a drug can be broadly or narrowly defined as any man-made, natural, or endogenous molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism. More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.

Ibuprofen Medication used for treating pain, fever, and inflammation

Ibuprofen is a medication in the nonsteroidal anti-inflammatory drug (NSAID) class that is used for treating pain, fever, and inflammation. This includes painful menstrual periods, migraines, and rheumatoid arthritis. It may also be used to close a patent ductus arteriosus in a premature baby. It can be used by mouth or intravenously. It typically begins working within an hour.

GlaxoSmithKline British pharmaceutical company

GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in Brentford, England. Established in 2000, by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company according to Forbes as of 2019, after Pfizer, Novartis, Roche, Sanofi, and Merck & Co. GSK is the tenth largest pharmaceutical company and #296 on the 2019 Fortune 500, ranked behind other pharmaceutical companies including China Resources, Johnson & Johnson, Roche, Sinopharm, Pfizer, Novartis, Bayer, Merck, and Sanofi.

ProQuest American information company

ProQuest LLC is an Ann Arbor, Michigan-based global information-content and technology company, founded in 1938 as University Microfilms by Eugene B. Power. ProQuest provides applications and products for libraries. Its resources and tools support research and learning, publishing and dissemination, and the acquisition, management and discovery of library collections.

Medicinal chemistry scientific branch of pharmaceutical chemistry

Medicinal chemistry and pharmaceutical chemistry are disciplines of pharmacy at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with design, chemical synthesis and development for market of pharmaceutical agents, or bio-active molecules (drugs).

Eugene Garfield American scientist

Eugene Eli Garfield was an American linguist and businessman, one of the founders of bibliometrics and scientometrics. He helped to create Current Contents, Science Citation Index (SCI), Journal Citation Reports, and Index Chemicus, among others, and founded the magazine The Scientist.

Dr. Reddy's Laboratories is a multinational pharmaceutical company. The company was founded by Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited, of Hyderabad, India. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.

James Thomson (cell biologist) American developmental biologist

James Alexander Thomson is an American developmental biologist best known for deriving the first human embryonic stem cell line in 1998 and for deriving human induced pluripotent stem cells (iPS) in 2007.

Paul Adriaan Jan, Baron Janssen was a Belgian physician. He was the founder of Janssen Pharmaceutica, a pharmaceutical company with over 20,000 employees which is now a subsidiary of Johnson & Johnson.

ChemSpider database of chemicals owned by the Royal Society of Chemistry; see P661

ChemSpider is a database of chemicals. ChemSpider is owned by the Royal Society of Chemistry.

Thomson Reuters Canada-based media company

Thomson Reuters Corporation is a Canadian multinational media conglomerate. The company was founded in Toronto, Ontario, Canada, where it is headquartered at 333 Bay Street.

Robert Lefkowitz American physician and biochemist

Robert Joseph Lefkowitz is an American physician and biochemist. He is best known for his groundbreaking discoveries that reveal the inner workings of an important family G protein-coupled receptors, for which he was awarded the 2012 Nobel Prize for Chemistry with Brian Kobilka. He is currently an Investigator with the Howard Hughes Medical Institute as well as a James B. Duke Professor of Medicine and Professor of Biochemistry and Chemistry at Duke University.

Reuters International news organization based in London and owned by Thomson Reuters

Reuters is an international news organization owned by Thomson Reuters. Until 2008, the Reuters news agency formed part of an independent company, Reuters Group plc, which was also a provider of financial market data. Since the acquisition of Reuters Group by the Thomson Corporation in 2008, the Reuters news agency has been a part of Thomson Reuters, making up the media division. It was established in 1851.

Gajendra Pal Singh Raghava Indian scientist

Gajendra Pal Singh Raghava is an Indian bio-informatician and head of computational biology at the Indraprastha Institute of Information Technology.

<i>Pharmacotherapy</i> (journal) Academic journal

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy is a monthly peer-reviewed medical journal covering human pharmacology and pharmacotherapy, published by Wiley-Blackwell on behalf of the American College of Clinical Pharmacy, of which it is an official journal. It was established in 1981 under founding editor-in-chief Russel R. Miller. The second editor was Richard T. Scheife. The third and current editor is C. Lindsay DeVane. Initially published six times a year the journal has been a monthly since 1991.

<i>MedChemComm</i> Academic journal

MedChemComm is a peer-reviewed scientific journal publishing original (primary) research and review articles on all aspects of medicinal chemistry, including drug discovery, pharmacology and pharmaceutical chemistry. It is published monthly by the Royal Society of Chemistry in partnership with the European Federation for Medicinal Chemistry, of which it is the official journal. Authors can elect to have accepted articles published as open access. According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.495, ranking it 27th out of 59 journals in the category "Chemistry, Medicinal" and 163 out of 289 journals in the category "Biochemistry & Molecular Biology".

Open PHACTS is a European initiative public–private partnership between academia, publishers, enterprises, pharmaceutical companies and other organisations working to enable better, cheaper and faster drug discovery. It has been funded by the Innovative Medicines Initiative, selected as part of three projects to "design methods for common standards and sharing of data for more efficient drug development and patient treatment in the future".

The Esteve Foundation is a non-profit, internationally focused institution with the primary goal of fostering progress in pharmacotherapy by ways of scientific communication and discussion. The Foundation organizes international symposiums, roundtables, and discussion groups. It also helps disseminate quality scientific research by awarding a prize every two years for the best scientific article published by authors from Spain.

Phillip D. Zamore is an American molecular biologist and developed the first in vitro system for studying the mechanism of RNA interference (RNAi). He is the Gretchen Stone Cook Professor of Biomedical Sciences and Professor of Biochemistry and Molecular Pharmacology at University of Massachusetts Medical School, located in Worcester, Massachusetts. Zamore is the chair of the RNA Therapeutics Institute (RTI) at UMass Medical School, established in 2009, and has been a Howard Hughes Medical Institute Investigator since 2008. 

Dr. Alexandros Makriyannis is a professor of Chemistry and Chemical Biology in the Department of Medicinal Chemistry at Northeastern University in Boston, Massachusetts, where he directs the Center for Drug Discovery and holds the George Behrakis Chair of Pharmaceutical Biotechnology. His research has focused on the biochemical basis of the endocannabinoid system and on the development of synthetic cannabinoids.

References

  1. "Corporate Key Facts". ProusResearch.com. Retrieved 24 May 2014.
  2. "Prous Science Launches Integrity(R), the World's First Integrated Drug Discovery Portal". PRNewswire.com. 25 Jun 2001. Retrieved 21 May 2014.
  3. "Thomson Reuters Launches New Predictive Pharmacology Module As Part Of Its Prous Science Integrity Platform". Thomsonreuters.com. 28 Aug 2008. Retrieved 21 May 2014.
  4. "A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities". Toxicol Appl Pharmacol. 273 (3): 427–34. 15 Dec 2013. doi:10.1016/j.taap.2013.09.015.